Doxorubicin hydrochloride inj 2 mg per ml, 100 ml vial: Hospital supply issue

Supply issue Hospital only Active

Due to a shipping delay, the supplier, Sandoz, is out of stock of Doxorubicin hydrochloride inj 2 mg per ml, 100 ml vial (Pharmacode: 2730138).

Affected product

Due to a shipping delay, the supplier, Sandoz, is out of stock of Doxorubicin hydrochloride inj 2 mg per ml, 100 ml vial.

  • Presentation: Inj 2 mg per ml, 100 ml vial
  • Brand: Doxorubicin Hydrochloride
  • Pharmacode: 2730138
  • Price: $164.50
  • Measure / Qty: per 1

The listing will show in the HML when it is updated for 1 June.

Alternative product funded 1 May 2026

From 1 May 2026, Pharmac funded an alternative brand to ensure people can continue to access treatment.

  • Presentation: Inj 2 mg per ml, 100 ml vial
  • Brand: Adriamycin
  • Pharmacode: 2730138
  • Price: $164.50
  • Measure / Qty: per 1

Expected resupply

Pharmac is working closely with the supplier to understand when Doxorubicin Ebewe will be available again.

Prescribing and supplying an unapproved medicine 

Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people when there is supply issue affecting the registered brand.  

We know supplying an unapproved medicine is not ideal. In this case, however, this will allow people to continue to access an appropriate treatment.  

We apologise for any inconvenience this causes.  

Prescriber and pharmacist requirements for section 29 and 29A medicines – Medsafe website (external link) 

What patients need to know about unapproved medicines – Healthify website(external link) 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)